Alain Prochiantz is Emeritus Professor and Scientific Director of BrainEver SAS, a company specialized in neurological and psychiatric diseases.
In 1990, he started his Research Unit at Ecole Normale Supérieure where he investigated the signalling functions of homeoprotein transcription factors. He is a member of the French Academy of Sciences since 2003, became Professor at Collège de France in 2007 and chaired this institution from 2015 to 2019. As dean of the College de France, Prochiantz initiated PAUSE (Programme d’Accueil en Urgence des Scientifiques en Exil) and chaired its Scientific Council and its Steering Committee, and he still participates in the selection of refugees and the identification of host laboratories.
The page has been updated in May 2024.
